Today: 15 May 2026
Browse Category

NASDAQ:CRNX 26 September 2025 - 7 January 2026

Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals shares fell about 8% Thursday after a regulatory filing disclosed Chief Medical and Development Officer Dr. Dana Pizzuti will step down December 31. She will transition to a Strategic Regulatory and Development Advisor role in early 2026. The stock traded in the low-to-high $40s as investors reacted to the leadership change.
18 December 2025
·
Massive Moves: Record Deals, FDA Wins & Crypto Mania Propel Top Stock Gainers (Sep 29, 2025)

Massive Moves: Record Deals, FDA Wins & Crypto Mania Propel Top Stock Gainers (Sep 29, 2025)

Electronic Arts shares jumped 15% after agreeing to a $55 billion buyout led by Saudi Arabia’s PIF, offering $210 per share. Crinetics Pharmaceuticals soared 28% as the FDA approved its oral acromegaly drug. QMMM Holdings surged 19% before the SEC halted trading over suspected manipulation. Scholar Rock gained 12% despite an FDA delay for its spinal atrophy drug.
29 September 2025
·····
Crinetics (CRNX) Stock Skyrockets on FDA Approval – Full 2025 Investor Update

Crinetics (CRNX) Stock Skyrockets on FDA Approval – Full 2025 Investor Update

Crinetics Pharmaceuticals shares surged 28% to around $46 on Sept. 26 after the FDA approved its first drug, Palsonify, for acromegaly. Trading volume spiked nearly tenfold amid heavy short-covering. The company plans to launch Palsonify in October at a $290,000 annual list price. Crinetics holds $1.2 billion in cash and no debt, with analysts raising price targets following the approval.
26 September 2025
··

Stock Market Today

  • Strategy Moves to Retire $1.5 Billion Convertible Debt, May Sell Bitcoin
    May 15, 2026, 12:26 PM EDT. Strategy announced an agreement to repurchase $1.5 billion of its 2029 convertible senior notes for about $1.38 billion, marking its first major step to reduce its $8.2 billion debt pile. The firm revealed it may fund the repurchase by selling Bitcoin holdings. Strategy, which controls $65 billion in Bitcoin, aims to 'equitize' its debt by allowing note holders to convert debt to stock. Despite Bitcoin's volatility and losses earlier this year, the company's stock has gained 18% year-to-date but remains below last year's highs. The sale of Bitcoin to manage debt and dividends signals a significant shift from the company's previous 'buy-and-hold' stance on the cryptocurrency.

Latest articles

Apple’s OpenAI Deal Hits Legal Turbulence Before WWDC AI Reveal

Apple’s OpenAI Deal Hits Legal Turbulence Before WWDC AI Reveal

15 May 2026
OpenAI is considering legal action against Apple after their ChatGPT-iPhone partnership failed to deliver deeper integration and subscription growth, sources told Reuters and the Financial Times. OpenAI’s lawyers are working with an outside firm on possible breach-of-contract steps. Apple is expected to detail more AI plans at WWDC, set for June 8-12. Apple shares rose about 1% Friday.
IREN Stock Drops After $3 Billion Debt Deal: Why Nvidia’s AI Bet Just Got More Expensive

IREN Stock Drops After $3 Billion Debt Deal: Why Nvidia’s AI Bet Just Got More Expensive

15 May 2026
IREN closed a $3.0 billion convertible senior notes sale to fund its shift from bitcoin mining to AI data centers. Shares fell $3.94 to $54.46 late Friday morning after the announcement. The offering follows a $3.4 billion AI cloud contract and a 5GW infrastructure partnership with Nvidia. IREN reported a wider net loss of $247.8 million for the March quarter as it decommissioned mining hardware.
Why SoFi Technologies Stock Is Slipping After Its PrimaryBid Deal

Why SoFi Technologies Stock Is Slipping After Its PrimaryBid Deal

15 May 2026
SoFi Technologies shares fell 2.6% Friday morning after acquiring PrimaryBid technology assets to expand IPO access, with the deal completed May 8 for an undisclosed price. The stock traded at $15.61, valuing the company at $21.5 billion. First-quarter adjusted net revenue rose 41% to $1.1 billion, while net charge-offs increased to $201.6 million. SoFi kept its 2026 revenue outlook unchanged.
Go toTop